Pancreatic Cancer Research

ResearcherInsermNo recent work listed

Thierry Voisin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4320-5183; OpenAlex author ID A5021809095. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper

Papers 2

  1. The Orexin-A/OX1R System Induces Cell Death in Pancreatic Cancer Cells Resistant to Gemcitabine and Nab-Paclitaxel Treatment. Co-author DOI 10.3389/fonc.2022.904327↗
  2. In vitro, in vivo and ex vivo demonstration of the antitumoral role of hypocretin-1/orexin-A and almorexant in pancreatic ductal adenocarcinoma. Last author DOI 10.18632/oncotarget.24084↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Vinciane Rebours · 2 shared papers, 2018–2022 · strength 0.24
  2. Anne Couvelard · 2 shared papers, 2018–2022 · strength 0.24
  3. Alain Couvineau · 2 shared papers, 2018–2022 · strength 0.24
  4. Stéphanie Dayot · 1 shared paper, 2018 · strength 0.07
  5. Philippe B Ruszniewski · 1 shared paper, 2018 · strength 0.07
  6. Jerome F. Cros · 1 shared paper, 2018 · strength 0.07
  7. Alain Sauvanet · 1 shared paper, 2018 · strength 0.07
  8. Valérie Paradis · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.